citric acid, anhydrous has been researched along with Multiple Sclerosis in 2 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Using gold (Au) NPs with different surface properties and corona composition, we have developed a technology for the discrimination and detection of two neurodegenerative diseases, Alzheimer's disease (AD) and multiple sclerosis (MS)." | 3.85 | Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces. ( Aghaie, A; Aghamollaii, V; Aghaverdi, H; Alekhamis, Z; Atyabi, F; Azhdarzadeh, M; Bargahi, A; Derakhshankhah, H; Ghasemi, F; Hajipour, MJ; Hashemi, E; Linne, U; Lotfabadi, A; Mahmoudi, M; Mashhadi, MM; Nabipour, I; Raoufi, M; Sheibani, S; Tafakhori, A; Vali, H, 2017) |
| "Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are inflammatory diseases of the central nervous system." | 1.46 | Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance. ( Hyun, JS; Jeong, IH; Kim, HH; Kim, HJ; Kong, BS; Park, SJ, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HH | 1 |
| Jeong, IH | 1 |
| Hyun, JS | 1 |
| Kong, BS | 1 |
| Kim, HJ | 1 |
| Park, SJ | 1 |
| Hajipour, MJ | 1 |
| Ghasemi, F | 1 |
| Aghaverdi, H | 1 |
| Raoufi, M | 1 |
| Linne, U | 1 |
| Atyabi, F | 1 |
| Nabipour, I | 1 |
| Azhdarzadeh, M | 1 |
| Derakhshankhah, H | 1 |
| Lotfabadi, A | 1 |
| Bargahi, A | 1 |
| Alekhamis, Z | 1 |
| Aghaie, A | 1 |
| Hashemi, E | 1 |
| Tafakhori, A | 1 |
| Aghamollaii, V | 1 |
| Mashhadi, MM | 1 |
| Sheibani, S | 1 |
| Vali, H | 1 |
| Mahmoudi, M | 1 |
2 other studies available for citric acid, anhydrous and Multiple Sclerosis
| Article | Year |
|---|---|
Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
Topics: Acetates; Acetone; Adolescent; Adult; Aged; Child; Citric Acid; Female; Formates; Glucose; Humans; H | 2017 |
Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.
Topics: Alzheimer Disease; Citric Acid; Colorimetry; Cysteamine; Female; Gold; Humans; Male; Metal Nanoparti | 2017 |